View More Recent Stories
-
Lipocine Inc (LPCN) PT Raised to $5 at H.C. Wainwright on Incremental NASH Value Contribution
-
UPDATE: H.C. Wainwright Starts Verrica Pharmaceuticals (VRCA) at Buy
-
UPDATE: H.C. Wainwright Starts Taiwan Liposome Co Ltd. (4152:TT) (TLC) at Buy
-
H.C. Wainwright Starts Novan (NOVN) at Buy
-
H.C. Wainwright Downgrades Corium International (CORI) to Neutral Following Acquisition
-
SCYNEXIS (SCYX) PT Lowered to $4.50 at H.C. Wainwright
-
Antares Pharma (ATRS) PT Raised to $4.50 at H.C. Wainwright
-
H.C. Wainwright Assumes Zynerba Pharmaceuticals (ZYNE) at Buy
-
UPDATE: H.C. Wainwright Assumes Pacira Pharmaceuticals (PCRX) at Buy
-
UPDATE: H.C. Wainwright Starts MannKind (MNKD) at Buy
-
H.C. Wainwright Assumes AcelRx Pharmaceuticals (ACRX) at Buy
-
H.C. Wainwright Assumes Agile Therapeutics (AGRX) at Buy
-
UPDATE: H.C. Wainwright Starts Corium International (CORI) at Buy
-
Jefferies Boosts PT on Antares Pharma (ATRS) 20% into OTREXUP PDUFA; Maintains Buy
-
Orexigen's (OREX) MAA Submission for Contrave Means Trajectory is Panning Out - Analyst
-
Pacira Pharmaceuticals (PCRX) PT Ratcheted Up to $58 at Jefferies
-
Jefferies Lifts PT on AcelRx Pharmaceuticals (ACRX) to $14

